Change - Announcement of Cessation::Cessation of Independent Non-Executive Director - Ms Leow Siew Yon, Cynthia
Issuer & Securities
META HEALTH LIMITED
META HEALTH LIMITED - SG1O81915033 - 5DX
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Cessation of Independent Non-Executive Director - Ms Leow Siew Yon, Cynthia
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Description (Please provide a detailed description of the event in the box below)
Cessation of Independent Non-Executive Director.
This announcement has been prepared by Meta Health Limited (the "Company") and its contents have been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor"), in accordance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr Alex Tan, Chief Executive Officer, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.
Name Of Person
Leow Siew Yon, Cynthia
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Ms Leow is stepping down as an Independent Non-Executive Director of the Company to devote more time to her principal work commitment. Following Ms Leow's resignation, Ms Leow will also cease to be the Chairman of the Nominating Committee, and a member of the Audit Committee and the Remuneration Committee of the Company.
After having interviewed Ms Leow and to the best of its knowledge, the Company's sponsor, ZICO Capital Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no other material reasons for the resignation of Ms Leow.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director, Chairman of the Nominating Committee, and a member of the Audit Committee and the Remuneration Committee.
Role and responsibilities
Assumed the role and responsibilities as an Independent Non-Executive Director, Chairman of the Nominating Committee, and a member of the Audit Committee and the Remuneration Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)
Confier Pte. Ltd.
Asgard Dss Pte. Ltd.
Ironman Marketing Pte. Ltd.